Takeda Challenges Claim Construction Rule At High Court
Takeda Pharmaceutical Co. Ltd. has asked the U.S. Supreme Court to nix the Federal Circuit's reversal of an infringement finding against Zydus Pharmaceuticals USA Inc. over its planned generic of the...To view the full article, register now.
Already a subscriber? Click here to view full article